Gene testing war looms for AstraZeneca heart drug
(Reuters)
Unusual Little Blurbs
Reuters - Gene testing is shaping up to be a marketing battleground for new blood thinners like AstraZeneca's Brilinta, underscoring the power and limitations of genetics as a tool to predict medical outcomes.
Source: Yahoo! News: Biotechnology News